All News AstraZeneca PLC

Equities

AZN

GB0009895292

Real-time Estimate Cboe Europe Other stock markets 07:16:13 2024-05-17 am EDT			5-day change	1st Jan Change
12,153 ^GBX	-0.11%		-1.97%	+14.40%

May. 16	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	MT
May. 16	Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	May. 16	MT
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	May. 16
AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	May. 16	AQ
AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K	May. 16	PU
AstraZeneca trials yield positive results for immunocompromised patients	May. 16	AN
AstraZeneca: positive results in Covid prevention	May. 16	CF
Insights into AstraZeneca's MANDARA Phase III data	May. 16	AQ
The FTSE 100 is taking a breather	May. 16
AstraZeneca's Antibody Cuts COVID-19 Risk Among Immunocompromised in Late-stage Study	May. 16	MT
Notice to the Annual General Meeting of Cline Scientific AB	May. 16	AQ
AstraZeneca PLC Phase III Trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population	May. 16	CI
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	May. 15	PU
ASTRAZENECA : UBS reiterates its Sell rating	May. 15	ZD
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	May. 15	AQ
FDA extends review of Ascendis Pharma's hormone disorder therapy	May. 14	RE
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	May. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT